COGENT BIOSCIENCES INC (COGT) Forecast, Price Target & Analyst Ratings

NASDAQ:COGTUS19240Q2012

Current stock price

35.42 USD
+0.21 (+0.6%)
At close:
35.42 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COGENT BIOSCIENCES INC (COGT).

Forecast Snapshot

Consensus Price Target

Price Target
$54.34
+ 53.41% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.55
Revenue Estimate

ChartMill Buy Consensus

Rating
85.26%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$54.34
Upside
+ 53.41%
From current price of $35.42 to mean target of $54.34, Based on 19 analyst forecasts
Low
$35.35
Median
$56.10
High
$75.60

Price Target Revisions

1 Month
2.61%
3 Months
8.52%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for COGT. The average price target is 54.34 USD. This implies a price increase of 53.41% is expected in the next year compared to the current price of 35.42.
The average price target has been revised upward by 8.52% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

COGT Current Analyst RatingCOGT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

COGT Historical Analyst RatingsCOGT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.26%
COGT was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about COGT.
In the previous month the buy percentage consensus was at a similar level.
COGT was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-17WedbushReiterate Outperform -> Outperform
2026-02-18Piper SandlerMaintains Overweight -> Overweight
2026-01-21WedbushReiterate Outperform -> Outperform
2026-01-06HC Wainwright & Co.Maintains Buy -> Buy
2025-12-19JP MorganMaintains Overweight -> Overweight
2025-12-08NeedhamReiterate Hold -> Hold
2025-11-13HC Wainwright & Co.Maintains Buy -> Buy
2025-11-11BairdMaintains Neutral -> Neutral
2025-11-10Leerink PartnersMaintains Outperform -> Outperform
2025-11-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-10-21JP MorganMaintains Overweight -> Overweight
2025-10-16StifelInitiate Hold
2025-09-03Raymond JamesInitiate Strong Buy
2025-08-25GuggenheimMaintains Buy -> Buy
2025-08-07JP MorganMaintains Overweight -> Overweight
2025-08-06HC Wainwright & Co.Maintains Buy -> Buy
2025-07-18CitigroupMaintains Buy -> Buy
2025-07-10JP MorganMaintains Overweight -> Overweight
2025-07-08GuggenheimReiterate Buy -> Buy
2025-07-08BairdMaintains Neutral -> Neutral
2025-07-08HC Wainwright & Co.Maintains Buy -> Buy
2025-07-07Leerink PartnersMaintains Outperform -> Outperform
2025-07-07JefferiesMaintains Buy -> Buy
2025-06-17NeedhamReiterate Hold -> Hold
2025-05-29JP MorganMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.55
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-6.09%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-1.52%
EPS (3 Months)
-23.38%

Next Earnings Summary

COGT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.55 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
COGT revenue by date.COGT revenue by date.
9.73M
16.39%
22.5M
131.24%
7.87M
-65.02%

-100.00%
19.986M366.46M
1,733.58%
763.72M
108.40%
1.201B
57.26%
1.583B
31.81%
1.862B
17.62%
2.156B
15.79%
2.503B
16.09%
EBITDA
YoY % growth
COGT ebitda by date.COGT ebitda by date.
-34.69M
-38.87%
-30.89M
10.95%
-81.48M
-163.77%
N/A
7.46%
N/A
-94.96%
-149.618M
-40.04%
-219.601M
-32.88%
-276.42M
-1.05%
-394.291M
-42.64%
-207.927M
47.27%
161.89M
177.86%
332.53M
105.40%
518.16M
55.82%
648.3M
25.12%
765.69M
18.11%
907.84M
18.56%
EBIT
YoY % growth
COGT ebit by date.COGT ebit by date.
-36.01M
-37.71%
-32.18M
10.64%
-82.2M
-155.44%
-72.229M
8.09%
-145.387M
-95.68%
-206.407M
-40.78%
-277.255M
-32.61%
-323.348M
-17.16%
-375.669M
-16.18%
-141.273M
62.39%
129.04M
191.34%
530.58M
311.17%
834.24M
57.23%
932.8M
11.81%
1.116B
19.64%
1.347B
20.70%
Operating Margin
COGT operating margin by date.COGT operating margin by date.
-370.09%-143.02%-1,044.47%N/AN/AN/AN/AN/A-1,879.66%-38.55%16.90%44.18%52.70%50.10%51.76%53.82%
EPS
YoY % growth
COGT eps by date.COGT eps by date.
-6.40-4.20
34.38%
-8.10
-92.86%
-1.75
77.16%
-2.39
-32.43%
-2.37
2.04%
-2.48
17.92%
-2.28
-10.91%
-2.16
1.12%
-0.38
82.59%
1.14
403.34%
2.57
125.51%
4.01
55.90%
5.41
34.77%
6.34
17.26%
7.55
19.15%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.55
-6.09%
-0.56
-5.85%
-0.58
-16.45%
-0.53
16.47%
-0.25
54.70%
-0.27
52.73%
0.03
104.38%
0.20
137.50%
Revenue
Q2Q % growth
2.675M17.59M55.38M87.264M129.21M
4,730.28%
175.13M
895.62%
EBITDA
Q2Q % growth
-93.197M
-25.45%
-98.797M
-32.99%
-101.725M
-24.94%
-87.557M
9.67%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-97.979M
-30.76%
-99.806M
-32.05%
-103.25M
-23.87%
-94.041M
5.48%
-60.722M
38.03%
-48.818M
51.09%
-29.051M
71.86%
-7.969M
91.53%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

COGT Yearly Revenue VS EstimatesCOGT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
COGT Yearly EPS VS EstimatesCOGT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
36.12%
EPS Next 5 Year
30.85%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
7.72%
EBIT Next 5 Year
26.19%

COGENT BIOSCIENCES INC / COGT Forecast FAQ

Can you provide the average price target for COGENT BIOSCIENCES INC stock?

19 analysts have analysed COGT and the average price target is 54.34 USD. This implies a price increase of 53.41% is expected in the next year compared to the current price of 35.42.

Can you provide the upcoming earnings date for COGENT BIOSCIENCES INC?

COGENT BIOSCIENCES INC (COGT) will report earnings on 2026-05-04.

What are the consensus estimates for COGENT BIOSCIENCES INC (COGT) next earnings?

The consensus EPS estimate for the next earnings of COGENT BIOSCIENCES INC (COGT) is -0.55 USD and the consensus revenue estimate is 0 USD.

Can you provide the consensus rating for COGENT BIOSCIENCES INC stock?

The consensus rating for COGENT BIOSCIENCES INC (COGT) is 85.2632 / 100 . This indicates that analysts generally have a positive outlook on the stock.